Salvatore G.
- Country
- Germany
- Department
- Oncologia Medica
Research Overview
- Efficacy and Safety of PF-08634404 Plus Combination Therapy Versus Pembrolizumab Plus Combination Therapy in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Comparison of Sotorasib Plus Combination Therapy Versus Pembrolizumab Plus Combination Therapy in PD-L1 Negative KRAS p.G12C Positive Advanced Non-Squamous NSCLC
- Phase 1b/2 Study of PF-08634404 in Combination with Sigvotatug Vedotin or Other Anticancer Agents in Participants with Advanced Solid Tumors
Data & Insights
Has run more than one trial at 265 of 532 partner sites.
Specializations
Lung Cancer Research
The investigator specializes in treating various forms of non-small cell lung cancer (NSCLC), with particular emphasis on advanced and metastatic disease states. Their research encompasses both early-stage and advanced cancer treatments, including neoadjuvant and adjuvant therapeutic approaches.
- EGFR mutation-positive NSCLC
- KRAS G12C mutation studies
- Squamous and non-squamous NSCLC variants
Their work extends to investigating novel therapeutic combinations and targeted treatments for specific genetic mutations in lung cancer.
Precision Medicine
The investigator focuses on biomarker-driven treatment approaches and personalized medicine strategies. Their research includes evaluation of targeted therapies and immunological treatments across various cancer types.
- Tumor-agnostic precision oncology
- Biomarker-selected therapy protocols
- Molecular targeting strategies
Special attention is given to developing treatment protocols based on specific genetic alterations and biomarker profiles.
Innovative Therapeutics
The investigator's work involves evaluating novel therapeutic agents and combination treatments. Their research includes studies of immunotherapy approaches and targeted molecular therapies.
- Antibody-drug conjugates
- Immune checkpoint inhibitors
- Combination therapy strategies
Research efforts focus on comparing innovative treatments with established standards of care in oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.